Pfizer invested in blockchain science startup

Pfizer announced that their venture arm has invested in blockchain startup VitaDAO. At the moment, this has affected the value of the token very well, due to which the value of VitaDAO has risen by 64% from yesterday's figure. At the time of writing, VITA is priced at $1.81. A few hours ago, investors could purchase tokens at a cost of $1.12.

The investment round for VitaDAO was closed as a result with a substantial amount of $4,100,000 raised. In addition to Pfizer, other companies participated in the round, including Shine Capital, L1 Digital, Beaker DAO and Spaceship DAO. Of the individual entrepreneurs, Balaji Srinivasan, the former CTO of Coinbase, also appeared on the list as an investor.

Pfizer's venture arm's investment in VitaDAO looks very logical, as this decentralized blockchain project is funding longevity research and other scientific developments that help improve human life expectancy.

Notably, this approach to science has spawned a new sector in decentralized technology. It is called DeSci (Decentralized Science) - decentralized science. Instead of scientific research receiving financial support through a centralized method, the method of decentralized fees is now increasingly widespread, and DeSci can give a strong impetus to the advancement of science.

Last year, VitaDAO donated 30,000 euros to support the development of an accelerated method for the early detection of Alzheimer's disease. This method was researched by Mantis Photonics, which received the money. In addition, VitaDAO donated $250,000 to the University of Copenhagen to help study the effects of drugs on the human aging process.

Pfizer announced in a press release that they have become the first pharmaceutical company in the world to support VitaDAO's activities. Representatives of the corporation also announced that they would take part in various community votes and help evaluate their various actions from the point of view of science. Pfizer will provide all possible assistance in the development of VitaDAO projects and will sponsor the activities of this DeSci project.

At the moment, as mentioned earlier, the cost of the VitaDAO token is $1.81, which is 64% more than yesterday's figures. Over the past 24 hours, traders have traded for $2,100,000, and the project capitalization at the moment is $15,400,000. In the future, VitaDAO may enlist the support of other similar pharmaceutical companies and other corporations. who are involved in the field of medicine, which can lead to even greater growth.